These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Systemic treatment of Kaposi's sarcoma: current status and future directions. Lilenbaum RC; Ratner L AIDS; 1994 Feb; 8(2):141-51. PubMed ID: 7519018 [TBL] [Abstract][Full Text] [Related]
44. Interferon treatment in acute progressive and fulminant hepatitis. Levin S; Leibowitz E; Torten J; Hahn T Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521 [TBL] [Abstract][Full Text] [Related]
45. Role of interferon in clinical practice. Sréter L; Fehér J Ther Hung; 1991; 39(4):159-66. PubMed ID: 1725832 [TBL] [Abstract][Full Text] [Related]
46. [Interferon in the treatment of virus diseases]. Abb J Internist (Berl); 1983 Nov; 24(11):627-31. PubMed ID: 6197388 [No Abstract] [Full Text] [Related]
47. [Infection by the human immunodeficiency virus (HIV) in French Guyana. Dermato-venereologic problems]. Pradinaud R; Sainte-Marie D; Girardeau I; Cassiede P Med Trop (Mars); 1989; 49(1):21-8. PubMed ID: 2725241 [TBL] [Abstract][Full Text] [Related]
51. Human interferon as a therapeutic agent--current status. Merigan TC N Engl J Med; 1983 Jun; 308(25):1530-1. PubMed ID: 6190083 [No Abstract] [Full Text] [Related]
52. The history of interferon and its use in animal therapy. Young AS; Cummins JM East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS31-63. PubMed ID: 2226234 [TBL] [Abstract][Full Text] [Related]
53. Kaposi's sarcoma in AIDS patients: long-term treatment with recombinant interferon alpha-2a and chemotherapy. Flepp M; Täuber MG; Lüthy R; Siegenthaler W Klin Wochenschr; 1988 May; 66(10):437-42. PubMed ID: 3135432 [TBL] [Abstract][Full Text] [Related]
54. [Antineoplastic effects of interferons]. Shimoyama M Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409 [No Abstract] [Full Text] [Related]
55. [Therapy of AIDS-induced Kaposi sarcoma and malignant melanoma with interferons]. Stadler R; Bratzke B; Mayer da Silva A; Orfanos CE Onkologie; 1988 Aug; 11(4):166-76. PubMed ID: 3054668 [TBL] [Abstract][Full Text] [Related]
56. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. Pinto AJ; Morahan PS; Brinton M; Stewart D; Gavin E J Interferon Res; 1990 Jun; 10(3):293-8. PubMed ID: 1696607 [TBL] [Abstract][Full Text] [Related]
57. Redefining the role of interferon in the treatment of malignant diseases. Bracarda S; Eggermont AM; Samuelsson J Eur J Cancer; 2010 Jan; 46(2):284-97. PubMed ID: 19906524 [TBL] [Abstract][Full Text] [Related]
58. Interferons in dermatology. Stadler R; Mayer-da-Silva A; Bratzke B; Garbe C; Orfanos C J Am Acad Dermatol; 1989 Apr; 20(4):650-6. PubMed ID: 2497154 [TBL] [Abstract][Full Text] [Related]
59. Interferon alpha in the treatment of AIDS-associated Kaposi's sarcoma. Kern P; Meigel W; Rácz P; Gottesleben A; Dettke T; Dietrich M Onkologie; 1987 Feb; 10(1):50-2. PubMed ID: 3295626 [TBL] [Abstract][Full Text] [Related]